Culture medium and protein supplementation in the generation and maturation of dendritic cells

Scandinavian Journal of Immunology

Volumn 63, Issue 6, 2006, Pages 401-409

  Royer, P J ^a   Tanguy Royer, S ^a   Ebstein, F ^a   Sapede, C ^a   Simon, T ^a   Barbieux, I ^a   Oger, R ^a   Gregoire, M ^a  

^a INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN SERUM ALBUMIN;

ANTIGEN PRESENTING CELL; ARTICLE; BLOOD AUTOTRANSFUSION; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINE; CELL MATURATION; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DENDRITIC CELL; FETAL CALF SERUM; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MONOCYTE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; QUALITY CONTROL; SERUM; STANDARD; SUPPLEMENTATION;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CULTURE MEDIA, SERUM-FREE; DENDRITIC CELLS; HUMANS; PHAGOCYTOSIS; PROTEINS; SERUM ALBUMIN;

EID: 33745525650     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.001757.x     Document Type: Article

References (32)

1. Cerundolo V, Hermans IF, Salio M. Dendritic cells: a journey from laboratory to clinic. Nat Immun 2004;5:7-10.
2. Steinman RM & Dhodapkar M. Active immunization against cancer with dendritic cells: the near future. Int J Cancer 2001;94:459-73.
3. Thurner B, Roder C, Dieckmann D et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods 1999;223:1-15.
4. Berger TG, Feuerstein B, Strasser E et al. Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories. J Immunol Methods 2002;268:131-40.
5. Rosenberg SA, Yang JC, Restifo NP. Cancer immunotherapy: moving beyond current vaccines. Nat Med 2004;10:909-15.
6. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. Nat Med 2004;10:475-80.
7. Schuler G, Schuler-Thurner B, Steinman RM. The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003;15:138-47.
8. Nestle FO, Banchereau J, Hart D. Dendritic cells: on the move from bench to bedside. Nat Med 2001;7:761-5.
9. Meierhoff G, Krause SW, Andreesen R. Comparative analysis of dendritic cells derived from blood monocytes or CD34+ hematopoietic progenitor cells. Immunobiology 1998;198:501-13.
10. Schuler G, Brang D, Romani N. Production and properties of large numbers of dendritic cells from human blood. Adv Exp Med Biol 1995;378:43-52.
11. Romani N, Reider D, Heuer M et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 1996;196:137-51.
12. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from non-proliferating progenitors in human blood. J Immunol Methods 1996;196:121-35.
13. Spisek R, Bretaudeau L, Barbieux I, Meflah K, Gregoire M. Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use. Cancer Immunol Immunother 2001;50:417-27.
14. Feuerstein B, Berger TG, Maczek C et al. A method for the production of cryopreserved aliquots of antigen-preloaded, mature dendritic cells ready for clinical use. J Immunol Methods 2000;245:15-29.
15. Zhou Y, Bosch ML, Salgaller ML. Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity. J Immunother 2002;25:289-303.
16. Thumann P, Moc I, Humrich J et al. Antigen loading of dendritic cells with whole tumor cell preparations. J Immunol Methods 2003;277:1-16.
17. Strome SE, Voss S, Wilcox R et al. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res 2002;62:1884-9.
18. Anton D, Dabadghao S, Palucka K, Holm G, Yi Q. Generation of dendritic cells from peripheral blood adherent cells in medium with human serum. Scand J Immunol 1998;47:116-21.
19. Sorg RV, Ozean Z, Brefort T et al. Clinical-scale generation of dendritic cells in a closed system. J Immunother 2003;26:374-83.
20. Tkachenko N, Wojas K, Tabarkiewicz J, Rolinski J. Generation of dendritic cells from human peripheral blood monocytes - comparison of different culture media. Folia Histochem Cytobiol 2005;43:25-30.
21. Peng JC, Thomas R, Nielsen LK. Generation and maturation of dendritic cells for clinical application under serum-free conditions. J Immunother 2005;28:599-609.
22. Duperrier K, Eljaafari A, Dezutter-Dambuyant C et al. Distinct subsets of dendritic cells resembling dermal DCs can be generated in vitro from monocytes, in the presence of different serum supplements. J Immunol Methods 2000;238:119-31.
23. Tuyaerts S, Noppe SM, Corthals J et al. Generation of large numbers of dendritic cells in a closed system using Cell Factories. J Immunol Methods 2002;264:135-51.
24. Bohnenkamp HR, Burchell JM, Taylor-Papadimitriou J, Noll T. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells. J Immunol Methods 2004;294: 67-80.
25. Haase C, Ejrnaes M, Juedes AE et al. Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo. Blood 2005;106:4225-33.
26. Mackensen A, Drager R, Schlesier M, Mertelsmann R, Lindemann A. Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed-dendritic cells. Cancer Immunol Immunother 2000;49:152-6.
27. Toldbod HE, Agger R, Bolund L, Hokland M. Potent influence of bovine serum proteins in experimental dendritic cell-based vaccination protocols. Scand J Immunol 2003;58:43-50.
28. Tarte K, Fiol G, Rossi JF, Klein B. Extensive characterization of dendritic cells generated in serum-free conditions: regulation of soluble antigen uptake, apoptotic tumor cell phagocytosis, chemotaxis and T cell activation during maturation in vitro. Leukemia 2000;14:2182-92.
29. Pietschmann P, Stockl J, Draxler S, Majdic O, Knapp W. Functional and phenotypic characteristics of dendritic cells generated in human plasma supplemented medium. Scand J Immunol 2000;51:377-83.
30. Vicari AP, Caux C, Trinchieri G. Tumour escape from immune surveillance through dendritic cell inactivation. Semin Cancer Biol 2002;12:33-42.
31. Spisek R, Bougras G, Ebstein F et al. Transient exposure of dendritic cells to maturation stimuli is sufficient to induce complete phenotypic maturation while preserving their capacity to respond to subsequent restimulation. Cancer Immunol Immunother 2003;52:445-54.
32. McIlroy D, Tanguy-Royer S, Le Meur N et al. Profiling dendritic cell maturation with dedicated microarrays. J Leukoc Biol 2005;78:794-803.